According to The Guardian, the U.S. has purchased “virtually all the stocks for the next three months” for the Gilead Sciences-manufactured drug, with the country prepared to outbid any other nation. RELATED: Looking for work?
These companies are hiring amid the coronavirus pandemicThe Trump administration has purchased more than 500,000 doses of the drug, according to The Guardian — all of Gilead’s July quantities available and 90% of doses available for August and September.Remdesivir has been frequently discussed as a potential treatment option for individuals with severe COVID-19 symptoms.
AdvertisementDuring the previously daily White House Coronavirus Task Force Press Briefings in previous months, President Donald Trump touted the.